{"id":"aspirin-simulation-agent","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This investigational agent is designed to replicate aspirin's dual action of inhibiting platelet aggregation and reducing inflammation, potentially through an alternative molecular pathway or improved delivery system. The exact mechanism remains proprietary to Tasly Biopharmaceuticals, but the goal is likely to achieve aspirin-like therapeutic benefits with potentially improved safety or efficacy profiles.","oneSentence":"An aspirin simulation agent mimics the antiplatelet and anti-inflammatory effects of aspirin through a novel mechanism or formulation approach.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:41.762Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular disease prevention or treatment (specific indication unclear from available information)"}]},"trialDetails":[{"nctId":"NCT03578822","phase":"PHASE3","title":"Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial","status":"COMPLETED","sponsor":"Tasly Biopharmaceuticals Co., Ltd.","startDate":"2018-08-10","conditions":"Acute Ischaemic Stroke","enrollment":149}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Aspirin simulation agent","genericName":"Aspirin simulation agent","companyName":"Tasly Biopharmaceuticals Co., Ltd.","companyId":"tasly-biopharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"An aspirin simulation agent mimics the antiplatelet and anti-inflammatory effects of aspirin through a novel mechanism or formulation approach. Used for Cardiovascular disease prevention or treatment (specific indication unclear from available information).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}